Video: Tips for Medication Management During Ramadan
Drug Topics
MARCH 29, 2023
Pharmacists can provide support and guidance to patients during their month of fasting.
Wed.Mar 29, 2023
467 
Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care
PhRMA
MARCH 29, 2023
The Patient Experience Survey (PES) series continues to reveal how health insurance is not working as it should for too many Americans — especially vulnerable groups. This series – including surveys of 5,000 Americans conducted with Ipsos, a leading research company in the United States — documents a consistent trend in reports of insurer- and middlemen-imposed practices that can keep patients from the medicines and treatments that they need.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Breaking: FDA Approves OTC Designation for Naloxone Nasal Spray
Drug Topics
MARCH 29, 2023
Naloxone hydrochloride nasal spray (Narcan) 4 mg is expected to be available over the counter in late summer 2023.
Woman of the Week: Psilera’s Jackie von Salm
PharmaVoice
MARCH 29, 2023
Psilera founder’s “third eye” approach to psychedelics ushers them into the therapeutic realm.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Reviewing Application For OTC Contraceptive
Drug Topics
MARCH 29, 2023
If approved, Perrigo’s Opill would be the first nonprescription birth control pill ever.
Seamless clinical trials were created to make studies easier — instead, they’ve become more complex
PharmaVoice
MARCH 29, 2023
Experts weigh in on how companies can design better trials that merge two phases into one.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
STAT
MARCH 29, 2023
A growing shortage of monkeys used for early-stage pharmaceutical research is causing concern that many companies will soon face costly delays starting clinical trials — leading to a slowdown in drug development. In recent weeks, the U.S Fish & Wildlife Service began denying company requests to import long-tailed macaques from Cambodia in the wake of a federal investigation into a smuggling ring.
UnitedHealthcare to begin reducing prior authorizations this summer
Fierce Healthcare
MARCH 29, 2023
UnitedHealthcare to begin reducing prior authorizations this summer pminemyer Wed, 03/29/2023 - 17:02
STAT+: Medical device companies now need to prove to FDA they’re protected against cyberattacks
STAT
MARCH 29, 2023
Hidden in this year’s federal spending bill, among major changes to Medicare payments to doctors and post-pandemic Medicaid , lies a little-noticed change with big implications: a mandate to protect medical devices connected to the internet from hacks or ransomware attacks. The law, which goes into effect Wednesday, explicitly states that companies cannot sell their connected medical devices without first showing the Food and Drug Administration a solid cybersecurity plan.
Signify Health CEO says CVS deal will 'turbocharge' home health provider's roadmap
Fierce Healthcare
MARCH 29, 2023
Signify Health CEO says CVS deal will 'turbocharge' home health provider's roadmap hlandi Wed, 03/29/2023 - 19:57
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pressure is building on pharma and biotech companies to take climate action
STAT
MARCH 29, 2023
As the health impacts of climate change become harder to ignore, biotechnology and pharmaceutical companies are facing increasing pressure from investors, employees, and government regulators to reduce their carbon emissions, and to make environmental sustainability a core part of their business. Globally, large public biotech and pharmaceutical companies are responsible for more than 200 million metric tons of carbon dioxide and equivalent emissions, according to estimates from one 2022 report.
Bipartisan Senate bill aims to take on Medicare Advantage up-coding practices
Fierce Healthcare
MARCH 29, 2023
Bipartisan Senate bill aims to take on Medicare Advantage up-coding practices rking Wed, 03/29/2023 - 17:02
STAT+: British Columbia to bar Americans from buying Ozempic over supply concerns
STAT
MARCH 29, 2023
British Columbia plans to limit sales of the popular diabetes drug Ozempic to Canadian residents in response to a wave of Americans flocking to local pharmacies in search of the drug, potentially straining supplies in the province. Ozempic, made by Novo Nordisk, is experiencing surging demand because it not only helps regulate blood sugar in people with diabetes, but can also help people lose weight.
Viking’s weight loss drug enters an already crowded arena
Pharmaceutical Technology
MARCH 29, 2023
Viking Therapeutics has announced the start of a Phase I clinical study to evaluate its dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist VK2735. The trial, which is investigating healthy adults with a minimum body mass index of 30 kg/m2, will see VK2735 administered as an oral tablet once daily for 28 days.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
New lupus partnership with FDA aims to end drug trials’ history of failure
STAT
MARCH 29, 2023
Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug Administration in six decades. A key partnership is looking to change that. On Wednesday, the nonprofit Lupus Research Alliance announced it was entering into a public-private partnership with the FDA.
Amazon Pharmacy rolls out coupon savings for branded medications
Drug Store News
MARCH 29, 2023
Amazon is working with GSK, Kaléo, Novo Nordisk and Dexcom to integrate coupons for their brand-name medications directly into the checkout experience on the Amazon Pharmacy website and app.
FDA approves over-the-counter Narcan. Here’s what it means
STAT
MARCH 29, 2023
The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter. It’s a move that some advocates have long sought as a way to improve access to a lifesaving drug, though the exact impact will not be clear immediately.
The best SingleCare reviews this March
The Checkup by Singlecare
MARCH 29, 2023
This March, we may have changed our clocks for the last time. Whether or not you’re excited that daylight saving time might come to an end, there’s something we can all celebrate–it’s officially spring! And that, of course, means warmer weather and longer days. But if you’re one of the 81 million adults in the United States with seasonal allergies, you may be experiencing uncomfortable symptoms from all that pollen.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: New research may give geneticists a long-sought tool: a targeted protein delivery device
STAT
MARCH 29, 2023
Mark Hurst just wanted to kill some bugs. A newly credentialed bacteriologist working for the New Zealand government in the early 2000s, his job was to invent new and exciting weapons in the war against grass grubs, the squishy, ectoplasmic beetle larvae that had long bedeviled the islands’ farmers. Fortunately, there were already multiple strains of bacteria that infected and killed these insects.
Joah Beauty elevates eye looks with 3 new launches
Drug Store News
MARCH 29, 2023
New launches from the brand include the Color Haul Eyeshadow Palette, Simplifeyed Power Quad and Super Sidekick Eyeshadow Primer.
STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost
STAT
MARCH 29, 2023
In a rare move, the Dutch health ministry refused to provide coverage for a Gilead Sciences breast cancer treatment in a dispute over cost, one of the few times the government agency has taken such a step in recent years. In explaining the decision, Health Minister Ernst Kuipers maintained that the price Gilead sought to charge for its medication, known as Trodelvy, did not justify the health benefits.
CVS Health completes acquisition of Signify Health
Drug Store News
MARCH 29, 2023
Under the terms of the transaction, each outstanding share of Signify Health common stock is being exchanged for $30.50 in cash, representing a total transaction value of approximately $8 billion.
Opinion: Why the rise of DNA testing is creating challenges — and an opportunity
STAT
MARCH 29, 2023
Twenty years ago, virtually all people seeking genetic testing were individuals diagnosed with diseases possibly linked to their genetic makeup. Today, millions of people order genetic tests to learn about their ancestry, as well as to understand what their genes say about their future health. This rapid growth has created what some might see as a big problem and others might see as an opportunity.
Amazon Pharmacy rolls out coupon savings for branded medications
Drug Store News
MARCH 29, 2023
Amazon is working with GSK, Kaléo, Novo Nordisk and Dexcom to integrate coupons for their brand-name medications directly into the checkout experience.
STAT+: NIH releases data showing more clinical trial sponsors are reporting results, but most miss deadlines
STAT
MARCH 29, 2023
In response to mounting criticism, the National Institutes of Health published data that shows an improvement in the reporting of results from clinical trials sponsored by the agency. In fiscal year 2022, 41% of trial results were submitted to the federal database ClinicalTrials.gov, compared with 34% in the previous year and just 29% in fiscal year 2020.
BodyTech launches Peeps-flavored Whey Protein Isolate
Drug Store News
MARCH 29, 2023
BodyTech x Peeps Whey Protein Isolate is available in marshmallow and chocolate marshmallow flavors exclusively at The Vitamin Shoppe.
STAT+: Pharmalittle: WHO may add obesity drugs to essential medicines list; monkey shortage may delay drug development
STAT
MARCH 29, 2023
Good morning, everyone, and how are you today? We are doing just fine, thank you. After all, the birds are still chirping and a cool breeze is wafting by the placid Pharmalot campus. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation.
Solving the Omnichannel Puzzle
Pharmaceutical Commerce
MARCH 29, 2023
Why deploying AI and analytics in tandem is a key targeting tool.
Survey Shows the Terrifying Truth About America’s Healthcare Affordability Crisis: Patients Put off Care for Years due to Costs
Fierce Healthcare
MARCH 29, 2023
Survey Shows the Terrifying Truth About America’s Healthcare Affordability Crisis: Patients Put off Care for Years due to Costs mteefey Wed, 03/29/2023 - 19:41
Enlightened rolls out Frozen Greek Yogurt Bars
Drug Store News
MARCH 29, 2023
The frozen bars are available in caramel brownie and mint and cookies flavors.
Regeneron and Sonoma Biotherapeutics partner to develop T cell therapies
Pharmaceutical Technology
MARCH 29, 2023
Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The partnership will combine the VelociSuite technologies of Regeneron with Sonoma Biotherapeutics’ pioneering approach to develop and produce gene modified Treg cell therapies.
Augmented ablation offer no improvement over standard care for atrial fibrillation recurrence
Hospital Pharmacy Europe
MARCH 29, 2023
An double wide-area circumferential catheter ablation offered no added benefit to standard care in terms of atrial fibrillation recurrence The use of an augmented, double wide-area circumferential catheter ablation (WACA) has been found to be no better than the current, standard single WACA for the prevention of atrial fibrillation (AF) recurrence in patients with paroxysmal AF, according to a randomised trial by Canadian researchers.
Dollar General to expand beauty set in select stores
Drug Store News
MARCH 29, 2023
Dollar General is debuting a new beauty-focused layout, which includes more than 1,000 beauty, skin and hair care offerings.
Let's personalize your content